Residual – Medis Orbits

Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

New test as sensitive as next-generation sequencing, and provides five-day specimen stability to support nationwide testing…